TG2, a novel extracellular protein with multiple functions

Amino Acids

Volumn 42, Issue 2-3, 2012, Pages 939-949

  Wang, Zhuo ^a   Griffin, Martin ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cell adhesion and crosslinking; Extracellular matrix; Tissue transglutaminase

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTEGRIN; CARMUSTINE; COLLAGEN TYPE 1; DIHYDROISOXAZOLE DERIVATIVE; ENZYME INHIBITOR; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 INHIBITOR; PROTEIN KINASE C ALPHA; PROTEOHEPARAN SULFATE; SMALL INTERFERING RNA; SYNDECAN 4; UNCLASSIFIED DRUG; AMIDE; CALCIUM; MATRIX METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ANTINEOPLASTIC ACTIVITY; ATHEROSCLEROSIS; CANCER INHIBITION; CANCER RESISTANCE; CANCER SURVIVAL; CELL ADHESION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME REGULATION; ENZYME RELEASE; ENZYME STRUCTURE; EXTRACELLULAR SPACE; FIBROSIS; GLIOBLASTOMA; HUMAN; KIDNEY FUNCTION; MOLECULAR PATHOLOGY; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN CROSS LINKING; PROTEIN PROCESSING; REVIEW; SCAR FORMATION; SURVIVAL RATE; CHEMISTRY; EXTRACELLULAR MATRIX; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

AMIDES; CALCIUM; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MATRIX METALLOPROTEINASES; PROTEIN KINASE C-ALPHA; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSGLUTAMINASES;

EID: 84859632755     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1008-x     Document Type: Review

References (80)

1. Aeschlimann D, Paulsson M, Mann K (1992) Identification of Gln (726) in nidogen as the amine acceptor in transglutaminasecatalyzed cross-linking of laminin-nidogen complexes. J Biol Chem 267:11316-11321
2. Ahn JS, Kim MK, Hahn JH, Park JH, Park KH, Cho BR, Park SB, Kim DJ (2008) Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9. Biochem Biophys Res Commun 376:743-747
3. Akimov SS, Belkin AM (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98:1567-1576
4. Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825-838
5. Al-Jallad HF, Nakano Y, Chen JL Y, McMillan E, Lefebvre C, Kaartinen MT (2006) Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MOT3-E1 osteoblast cultures. Matrix Biol 25:135-148
6. Antonyak MA, Li B, Regan AD, Feng Q, Dusaban SS, Cerione RA (2009) Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J Biol Chem 284:17914-17925
7. Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M (2002) Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 277:16567-16575 (Pubitemid 34967673)
8. Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY (2001) Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276:18415-18422
9. Chau DYS, Collighan RJ, Verderio EAM, Addy VL, Griffin M (2005) The cellular response to transglutaminase-cross-linked collagen. Biomaterials 26:6518-6529 (Pubitemid 41021746)
10. Chen SH, Lin CY, Lee LT, Chang GD, Lee PP, Hung CC, Kao WT, Tsai PH, Schally AV, Hwang JJ, Lee MT (2010) Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells. Anticancer Res 30:4177-4186
11. Collighan RJ, Griffin M (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36:659-670
12. Dardik R, Inbal A (2006) Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 312: 2973-2982 (Pubitemid 44292656)
13. Forsprecher J, Wang Z, Nelea V, Kaartinen MT (2009) Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin. Amino Acids 36:747-753
14. Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, Griffin M (1999a) Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal betasandwich domain. J Biol Chem 274:30707-30714
15. Gaudry CA, Verderio E, Jones RA, Smith C, Griffin M (1999b) Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res 252:104-113 (Pubitemid 29485130)
16. Glass CK (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391-407 (Pubitemid 24180795)
17. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature's biological glues. Biochem J 368:377-396 (Pubitemid 35454517)
18. Griffin M, Mongeot A, Collighan R, Saint RE, Jones RA, Coutts IGC, Rathbone DL (2008) Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorg Med Chem Lett 18:5559-5562
19. Han BJ, Cho JW, Cho YD, Jeong CK, Kim SY, Lee BI (2010) Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. Int J Biol Macromol 47:190-195
20. Hand D, Bungay PJ, Elliott BM, Griffin M (1985) Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein. Biosci Rep 5:1079-1086 (Pubitemid 16141515)
21. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373:793-803 (Pubitemid 36981089)
22. Heath DJ, Christian P, Griffin M (2002) Involvement of tissue trans glutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices. Biomaterials 23:1519-1526 (Pubitemid 34037088)
23. Herman JF, Mangala LS, Mehta K (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25:3049-3058 (Pubitemid 43780469)
24. Huang Y, Fan J, Yang J, Zhu GZ (2008) Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. Mol Cellular Biochem 308:133-139 (Pubitemid 351167854)
25. Huang LH, Haylor JL, Hau Z, Jones RA, Vickers ME, Wagner B, Griffin M, Saint RE, Coutts IGC, El Nahas AM, Johnson TS (2009) Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int 76:383-394
26. Huang L, Haylor JL, Fisher M, Hau Z, El Nahas AM, Griffin M, Johnson TS (2010) Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy? Nephrol Dial Transplant 25:3897-3910
27. Janiak A, Zemskov EA, Belkin AM (2006) Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 17:1606-1619 (Pubitemid 44017561)
28. Johnson KA, Terkeltaub R (2005) External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 280:15004-15012 (Pubitemid 40562853)
29. Johnson TS, El-Koraie AF, Skill NJ, Baddour NM, El Nahas AM, Njloma M, Adam AG, Griffin M (2003) Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14:2052-2062 (Pubitemid 36909913)
30. Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, Griffin M (2006) Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 13:1442-1453 (Pubitemid 44210348)
31. Kang SK, Yi KS, Kwon NS, Park KH, Kim UH, Baek KJ, Im MJ (2004) Alpha(1B)-adrenoceptor signaling and cell motility - GTPase function of G(h)/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits. J Biol Chem 279:36593-36600 (Pubitemid 39129003)
32. Kausar T, Sharma R, Hasan MR, Tripathi SC, Saraya A, Chattopadhyay TK, Gupta SD, Ralhan R (2011) Clinical significance of GPR56, transglutaminase 2, and NF-kappaB in esophageal squamous cell carcinoma. Cancer Invest 29:42-48
33. Kiraly R, Csosz E, Kurtan T, Antus S, Szigeti K, Simon-Vecsei Z, Korponay-Szabo IR, Keresztessy Z, Fesus L (2009) Functional significance of five noncanonical Ca-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis. Febs J 276:7083-7096
34. Kleman JP, Aeschlimann D, Paulsson M, van der Rest M (1995) Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34:13768-13775
35. Kotsakis P, Wang Z, Collighan RJ, Griffin M (2010) The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26. Amino Acids (In press)
36. Kumar A, Xu J, Brady S, Gao H, Yu D, Reuben J, Mehta K (2010) Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells. PLoS One 5:e13390
37. Kuncio GS, Tsyganskaya M, Zhu J, Liu SL, Zern MA (1996) TNFalpha modulates expression of the tissue transglutaminase gene in human HEPG2 cells. Hepatology 24: 813
38. Lai TS, Slaughter TF, Peoples KA, Hettasch JM, Greenberg CS (1998) Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 273:1776-1781 (Pubitemid 28133710)
39. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, Greenberg CS (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40:4904-4910 (Pubitemid 32332535)
40. Lorand L, Radek JT, Jeong JM, Murthy SNP, Ingham KC (1993) Affinity of human red-cell transglutaminase for a 42 k gelatinbinding fragment of human plasma fibronectin. Faseb J 7:A1280
41. Mangala LS, Mehta K (2005) Tissue transglutaminase (TG2) in cancer biology. Prog Exp Tumor Res 38:125-138
42. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26:2459-2470 (Pubitemid 46597265)
43. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M (1996) Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ 7:179-186 (Pubitemid 26049826)
44. Mehta K, Fok JY, Mangala LS (2006) Tissue transglutaminase: from biological glue to cell survival cues. Front Biosci 11:173-185 (Pubitemid 43253484)
45. Mehta K, Kumar A, Kim HI (2010) Transglutaminase 2: a multitasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80:1921-1929
46. Mishra S, Murphy LJ (2004) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulinlike growth factor-binding protein-3 kinase. J Biol Chem 279:23863-23868 (Pubitemid 38725242)
47. Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Comm 339:726-730 (Pubitemid 41739727)
48. Mycek MJ, Clarke DD, Neidle A, Waelsch H (1959) Amine incorporation into insulin as catalyzed by transglutaminase. Arch Biochem Biophys 84:528-540
49. Nadalutti C, Viiri KM, Kaukinen K, Maki M, Lindfors K (2011) Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis. Cell Prolif 44:49-58
50. Nakano Y, Forsprecher J, Kaartinen MT (2010) Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures. J Cell Physiol 223:260-269
51. Nelea V, Nakano Y, Kaartinen MT (2008) Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2. Protein J 27:223-233
52. Peng XJ, Zhang YH, Zhang HF, Graner S, Williams JF, Levitt ML, Lokshin A (1999) Interaction of tissue transglutaminase with nuclear transport protein importin-alpha 3. FEBS Lett 446:35-39 (Pubitemid 29127245)
53. Quan G, Choi JY, Lee DS, Lee SC (2005) TGF-beta up-regulates transglutaminase two and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation. Arch Dermatol Res 297:84-90 (Pubitemid 41431547)
54. SanthanamL, Tuday EC,WebbAK, Dowzicky P, KimJH, Oh YJ, Sikka G, KuoM,HalushkaMK, MacgregorAMet al (2010)Decreased Snitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res 107:117-125
55. Scarpellini A, Germack R, Lortat-Jacob H, Muramtsu T, Johnson TS, Billett E, Verderio EA (2009) Heparan sulphate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J Biol Chem 284:18411-18423
56. Siegel M, Khosla C (2007) Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther 115:232-245 (Pubitemid 47042912)
57. Smethurst PA, Griffin M (1996) Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J 313:803-808
58. Sollid LM, Khosla C (2005) Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2:140-147 (Pubitemid 40812513)
59. Spurlin TA, Bhadriraju K, Chung KH, Tona A, Plant AL (2009) The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling. Biomaterials 30:5486-5496
60. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM (2010) Redox regulation of transglutaminase 2 activity. J Biol Chem 285:25402-25409
61. Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117:3389-3403 (Pubitemid 39139922)
62. Suto N, Ikura K, Sasaki R (1993) Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma Hepg2 cells. J Biol Chem 268:7469-7473 (Pubitemid 23105644)
63. Tanaka K, Yokosaki Y, Higashikawa F, Saito Y, Eboshida A, Ochi M (2007) The integrin alpha 5 beta 1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol 26:409-418 (Pubitemid 47081395)
64. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J et al (2009) Role of ransglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136:1783-1795
65. Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M (2008) Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem 283:20937-20947
66. Telci D, Collighan RJ, Basaga H, Griffin M (2009) Increased TG2 expression can result in induction of transforming growth factor beta 1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem 284:29547-29558
67. Toth B, Sarang Z, Vereb G, Zhang AL, Tanaka S, Melino G, Fesus L, Szondy Z (2009) Over-expression of integrin beta 3 can partially overcome the defect of integrin beta 3 signaling in transglutaminase 2 null macrophages. Imm Lett 126:22-28
68. Van Herck JL, Schrijvers DM, De Meyer GR, Martinet W, Van Hove CE, Bult H, Vrints CJ, Herman AG (2010) Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-e-deficient mice. J Vascular Res 47:231-240
69. Verderio E, Nicholas B, Gross S, Griffin M (1998) Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 239:119-138 (Pubitemid 28368484)
70. Verderio EA, Telci D, Okoye A, Melino G, Griffin M (2003) A novel RGD-independent cell adhesion pathway mediated by fibronectin- bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278:42604-42614 (Pubitemid 37310534)
71. Verderio EA, Johnson T, Griffin M (2004) Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 26:387-404 (Pubitemid 39093142)
72. Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 66:10525-10533 (Pubitemid 44799775)
73. Verma A, Guha S, Diagaradjane P, Kunnumakkara AB, Sanguino AM, Lopez-Berestein G, Sood AK, Aggarwal BB, Krishnan S, Gelovani JG, Mehta K (2008) Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clinical Cancer Res 14:2476-2483 (Pubitemid 351551083)
74. Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, Telci D, Griffin M (2010) RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and {alpha}5{beta}1 integrin co-signaling. J Biol Chem 285:40212-40229
75. Wang Z, Telci D, Griffin M (2011) Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 317:367-381
76. Xu L, Begum S, Hearn JD, Hynes RO (2006) GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 103:9023-9028 (Pubitemid 43902526)
77. Yuan L, Choi KH, Khosla C, Zheng X, Higashikubo R, Chicoine MR, Rich KM (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol Cancer Therapeut 4:1293-1302
78. Yuan L, Siegel M, Choi K, Khosla C, Miller CR, Jackson EN, Piwnica-Worms D, Rich KM (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26:2563-2573 (Pubitemid 46632005)
79. Zemskov EA, Loukinova E, Mikhailenko I, Coleman RA, Strickland DK, Belkin AM (2009) Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase. J Biol Chem 284:16693-16703
80. Zemskov EA, Mikhailenko I, Hsia RC, Zaritskaya L, Belkin AM (2011) Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One 6:e19414